Dextran T4 (MW 4,000)
Based on 1 Customer Validation
Dextran 4,000 is a mucus rheology modifier. The dextran molecules in Dextran 4,000 can reduce the cross-link density of mucus through osmotic effects and hydrogen bond substitution, and reduce viscoelasticity and improve the mucociliary/cough clearance index by destroying the DNA-mucin network structure in mucus. Dextran 4,000 has the ability to improve the rheological properties and clearance ability of cystic fibrosis (CF) sputum, and can be used in the study of inhalation therapy or aerosol delivery of mucostatic respiratory diseases. The Dextran series of compounds are also natural polysaccharide drug carriers that can be connected to drugs through covalent bonding methods such as ester bonds, amide bonds or click chemistry, or self-assembled to form carriers such as nanoparticles and hydrogels. Dextran is biodegradable and biocompatible, and can achieve targeted delivery and controlled release of drugs. Dextran derivatives can prolong the half-life of drugs, increase local concentrations, and reduce the activity of immune clearance.
For research use only. We do not sell to patients.
- CAS No.: 9004-54-0
- Formula: (C6H10O5)n
- Molecular Weight:3200-4800
-
Storage:
4°C, sealed storage, away from moisture and light
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)
Biological Activity
Dextran 4,000 (0.4% (4 mg/mL), 4% (40 mg/mL); 30 min) reduces sputum viscoelasticity, decreased spinnability, and increases mucociliary clearance index (MCI) and cough clearance index (CCI) in in vitro experiments with cystic fibrosis sputum and healthy dog ??mucus[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 9004-54-0
-
Appearance Solid
-
Molecular Weight 3200-4800
-
Formula (C6H10O5)n
-
Color White to off-white
-
SMILES
[Dextran T4 (MW 4,000)]
-
Synonyms
Dextran 4; Dextran D4; Dextran T4(MW 3200-4800)
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
4°C, sealed storage, away from moisture and light
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)
Solvent & Solubility
H2O : ≥ 100 mg/mL
* "≥" means soluble, but saturation unknown.
Purity & Documentation
-
Data Sheet (269 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Handling Instructions (2659 KB)
References
[1]. Chen F, et al. Preparation and application of dextran and its derivatives as carriers. Int J Biol Macromol. 2020 Feb 15;145:827-834. [Content Brief]
[2]. Feng W, et al. Improved clearability of cystic fibrosis sputum with dextran treatment in vitro. Am J Respir Crit Care Med. 1998 Mar;157(3 Pt 1):710-4. [Content Brief]
[3]. Finlay WH, et al. Lung delivery of aerosolized dextran. Am J Respir Crit Care Med. 2000 Jan;161(1):91-7. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)